Skip to main content

PTC Therapeutics

PTC Therapeutics Inc is a commercial-stage biopharmaceutical enterprise headquartered in South Plainfield, New Jersey. The company focuses on the discovery, development, and commercialization of orally administered medicines targeting rare genetic disorders and oncology conditions. Its clinical pipeline and commercial portfolio feature therapeutic products addressing nonsense mutation genetic diseases, spinal muscular atrophy, and rare rare metabolic conditions. Principal revenue is derived through direct commercial pharmaceutical sales, government health agency supply agreements, and licensing royalties. The enterprise serves patients globally. PTC Therapeutics Inc is publicly traded on the Nasdaq Stock Market.

9 of the funds FundTelligence covers report a position in PTC Therapeutics.

Legal name
PTC Therapeutics Inc
Sector
Health Care
Country
United States
Funds holding it
9

Funds holding PTC Therapeutics

Showing the 8 largest of 9 funds holding it.

Loading...